MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: A prospective study

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Manali, Effrosyni D ^a   Lyberopoulos, Panagiotis ^a   Triantafillidou, Christina ^a   Kolilekas, Likourgos F ^a   Sotiropoulou, Christina ^b   Milic Emili, Joseph ^c   Roussos, Charis ^b   Papiris, Spyros A ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 MINUTE WALK TEST; AGED; ARTICLE; BREATHING RATE; CARBON DIOXIDE TENSION; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART RATE; HUMAN; IDIOPATHIC DISEASE; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION; MALE; MEDICAL RESEARCH COUNCIL CHRONIC DYSPNEA SCALE; OXYGEN CONSUMPTION; OXYGEN SATURATION; POPULATION RESEARCH; PROGNOSIS; PROSPECTIVE STUDY; RELIABILITY; SCORING SYSTEM; SURVIVAL RATE; TIDAL VOLUME; TOTAL LUNG CAPACITY; CHRONIC DISEASE; CLINICAL TRIAL; DYSPNEA; EXERCISE TEST; FIBROSING ALVEOLITIS; HOSPITALIZATION; LUNG FUNCTION TEST; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; WALKING;

AGED; CHRONIC DISEASE; DYSPNEA; EXERCISE TEST; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 77952734061     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-32     Document Type: Article

References (44)

1. Katzenstein AL, Zisman AD, Litzky AL, Nguyen BT, Kotloff RM. Usual interstitial pneumonia. Histologic study of biopsy and explant specimens. Am J Surg Pathol 2002, 26:1567-1577. 10.1097/00000478-200212000-00004, 12459623.
2. American Thoracic Society; European Thoracic Society Idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277-304. American Thoracic Society; European Thoracic Society.
3. , . American Thoracic Society, European Respiratory Society, American College of Chest Physicians Idiopathic Pulmonary Fibrosis, diagnosis and treatment. International Consensus statement. Am J Respir Crit Care Med 2000, 161:646-64. American Thoracic Society, European Respiratory Society, American College of Chest Physicians.
4. Risk C, Epler GR, Gaensler EA. Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 1984, 5:69-74.
5. Sturani C, Papiris S, Galavotti V, Gunella G. Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine. Respiration 1986, 50:117-129. 10.1159/000194918, 3749613.
6. O'Donnell DE, Ora J, Webb KA, Laveneziana P, Jensen D. Mechanisms of activity related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009, 167:116-132. 10.1016/j.resp.2009.01.010, 19450767.
7. Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease. A population-based study. Am J Respir Crit Care Med 2008, 178:1257-1261. 10.1164/rccm.200805-725OC, 18755924.
8. Papadopoulos CE, Pitsiou G, Karamitsos TD, Karvounis HI, Kontakiotis T, Giannakoulas G, Efthimiadis GK, Argyropoulou P, Parharidis GE, Bouros D. Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 2008, 31:701-706. 10.1183/09031936.00102107, 18057055.
9. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992, 146:935-940.
10. Stendardi L, Grazzini M, Gigliotti F, Lotti P, Scano G. Dyspnea and leg effort during exercise. Res Med 2005, 99:933-942.
11. Marciniuk DD, Watts RE, Gallagher CG. Dead space loading and exercise limitation in patients with interstitial lung disease. Chest 1994, 105:183-189. 10.1378/chest.105.1.183, 8275730.
12. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996, 109:1566-1576. 10.1378/chest.109.6.1566, 8769513.
13. Agusti AGN, Roca J, Gea J, Wagner PD, Zaubet A, Rodringuez-Roisin R. Mechanisms of gas exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991, 143:219-225.
14. Baddini Martinez JA, Martinez TY, Lovetro Galhardo FP, de Castro Pereira CA. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit 2002, 8:CR405-410.
15. King TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001, 164:1171-1181.
16. Mahler DA, Rosiello RA, Harver A, Lentine T, McGorern JF, Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 1987, 135:1229-1233.
17. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, Watanabe F, Arizono S. Dyspnoea at 6 minute walk test in idiopathic pulmonary fibrosis: comparison with COPD. Respir Med 2007, 101:833-838. 10.1016/j.rmed.2006.06.030, 16962758.
18. Papiris SA, Daniil ZD, Malagari K, Kapotsis G, Sotiropoulou C, Milic-Emili J, Roussos C. The MRC scale in the estimation of disease severity in IPF. Respir Med 2005, 99:755-761. 10.1016/j.rmed.2004.10.018, 15878493.
19. Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality of life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med 2005, 16:105-112. 10.1016/j.ejim.2004.09.013, 15833676.
20. Manali ED, Stathopoulos G, Kollintza A, Kalomenidis I, Sotiropoulou C, Milic Emili J, Roussos C, Daniil J, Papiris SA. Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir Med 2008, 102:586-592. 10.1016/j.rmed.2007.11.008, 18162388.
21. Daniil Z, Kitsanta P, Kapotsis G, Matjioudaki M, Kollintza A, Karatza M, Milic-Emili J, Roussos C, Papiris S. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Res Res 2005, 6:81.
22. Papiris SA, Kollintza A, Karatza M, Manali ED, Sotiropoulou C, Milic-Emili J, Roussos C, Daniil Z. CD8+ lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J Inflamm (Lond) 2007, 4:14. 10.1186/1476-9255-4-14, 1906752, 17578573.
23. ATS/ACCP Statement of cardiopulmonary testing. Am J Respir Crit Care Med 2003, 167:211-277. 10.1164/rccm.167.2.211, 12524257.
24. ATS Statement: Guidelines for the 6 minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
25. Wells AU, Hirani N. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008, 63:v1-v58. 10.1136/thx.2008.101691, 18757459.
26. Kawut SM, O'Shea MK, Bartels MN, et al. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005, 99:1431-1439. 10.1016/j.rmed.2005.03.007, 15885995.
27. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP, Martinez F. Prognostic value of desaturation during a 6MWT in Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:1084-1090. 10.1164/rccm.200302-219OC, 12917227.
28. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Six-minute walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:659-664. 10.1164/rccm.200604-520OC, 2648057, 16778159.
29. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, Martinez FJ. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute walk test. Am J Respir Crit Care Med 2006, 174:803-809. 10.1164/rccm.200604-488OC, 2648064, 16825656.
30. Hallstand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The time walked test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005, 25:96-103. 10.1183/09031936.04.00137203, 15640329.
31. Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006, 100:1734-1741. 10.1016/j.rmed.2006.02.004, 16545950.
32. Eaton T, Young P, Milne D, Wells AU. Six minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005, 171:1150-1157. 10.1164/rccm.200405-578OC, 15640367.
33. Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T. Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 2003, 97:482-490. 10.1053/rmed.2002.1469, 12735664.
34. Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ, Flaherty KR. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:402-407. 10.1164/rccm.200802-241OC, 2648909, 19074597.
35. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993, 6(suppl 16):S5-S40.
36. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor. (Diffusing capacity). Report working party, standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993, 6(Suppl 16):S41-S52.
37. Mura M, Ferretti A, Ferro O, Zompatori M, Cavalli A, Schiavina M, Fabbri M. Functional predictors of exertional dyspnea, 6 min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis. Respiration 2006, 73:495-502. 10.1159/000089656, 16484770.
38. Wagner PD. Ventilation-perfusion matching during exercise. Chest 1992, 101:192S-198S.
39. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996, 153:976-980.
40. Weber KT, Janicki JS, McElroy A. Determination of aerobic capacity and the severity of chronic cardiac and respiratory failure. Circulation 1987, 76:VI40-VI45.
41. Wagner PD. Determinants of maximal oxygen transport and utilization. Ann Rev Physiol 1996, 58:21-50.
42. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, Coasts AJ. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997, 29:1585-1590. 10.1016/S0735-1097(97)00078-8, 9180123.
43. Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ. ERS Task Force Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007, 29:185-209. ERS Task Force.
44. Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dörr M, Ewert R, Schäper C. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Res Med 2009, 103:317-324.